Variant report
Variant | nsv965385 |
---|---|
Chromosome Location | chr3:85317830-85326702 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555712289 | chr3:85319815-85319816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190109157 | chr3:85319821-85319822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541737394 | chr3:85319829-85319830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs147041500 | chr3:85319853-85319854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs72919217 | chr3:85319860-85319861 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs545589125 | chr3:85319873-85319874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564040325 | chr3:85319881-85319882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs144141536 | chr3:85319882-85319883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182212082 | chr3:85319889-85319890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568042001 | chr3:85319897-85319898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369209166 | chr3:85319906-85319907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs115145359 | chr3:85319913-85319914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs61290738 | chr3:85319972-85319973 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs539265664 | chr3:85320022-85320023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557920003 | chr3:85320033-85320034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370462570 | chr3:85320043-85320044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150666822 | chr3:85320114-85320115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537549638 | chr3:85320170-85320171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs59333278 | chr3:85320198-85320199 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs573988718 | chr3:85320206-85320207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533300938 | chr3:85320219-85320220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187588778 | chr3:85320247-85320248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553723611 | chr3:85320307-85320308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs578241003 | chr3:85320333-85320334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112140528 | chr3:85320346-85320347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570266890 | chr3:85320358-85320359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs138830366 | chr3:85320453-85320454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs56730325 | chr3:85320454-85320455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs377755129 | chr3:85320462-85320463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563881912 | chr3:85320464-85320465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576100030 | chr3:85320486-85320487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs370912240 | chr3:85320510-85320511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs543491990 | chr3:85320525-85320526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374153601 | chr3:85320536-85320537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs377500055 | chr3:85320552-85320553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs374206271 | chr3:85320567-85320568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528882347 | chr3:85320585-85320586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs190322752 | chr3:85320660-85320661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs535558491 | chr3:85320688-85320689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559259235 | chr3:85320689-85320690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs371007961 | chr3:85320690-85320691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs180999227 | chr3:85320695-85320696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555853922 | chr3:85320706-85320707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536806281 | chr3:85320767-85320768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs185063685 | chr3:85320785-85320786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs113644830 | chr3:85320841-85320842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533402129 | chr3:85320844-85320845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114617751 | chr3:85320849-85320850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs201627769 | chr3:85320862-85320863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs149406522 | chr3:85320870-85320871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Autism | 22102821 | CNVD |
Prostate cancer | 21307934 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:85319800-85320200 | Enhancers | Fetal Lung | lung |
2 | chr3:85320200-85320600 | Weak transcription | Fetal Lung | lung |
3 | chr3:85320600-85320800 | Enhancers | Fetal Lung | lung |
4 | chr3:85320800-85321800 | Weak transcription | Fetal Lung | lung |
5 | chr3:85321800-85322000 | Enhancers | Fetal Lung | lung |
6 | chr3:85321800-85322400 | Enhancers | Brain Inferior Temporal Lobe | brain |
7 | chr3:85322000-85322200 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
8 | chr3:85322400-85322800 | Weak transcription | Brain Inferior Temporal Lobe | brain |
9 | chr3:85322800-85323200 | Enhancers | Brain Inferior Temporal Lobe | brain |
10 | chr3:85323000-85323200 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
11 | chr3:85323600-85324000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |